1/12
10:32 am
atrc
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 [Yahoo! Finance]
Medium
Report
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 [Yahoo! Finance]
1/12
10:21 am
atrc
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
Medium
Report
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
12/25
07:32 pm
atrc
AtriCure (ATRC): Assessing Valuation After First-In-Human PFA/RFA Procedures and Renewed Analyst Optimism [Yahoo! Finance]
Low
Report
AtriCure (ATRC): Assessing Valuation After First-In-Human PFA/RFA Procedures and Renewed Analyst Optimism [Yahoo! Finance]
12/25
07:32 am
atrc
Assessing AtriCure's Valuation After a 33.4% Rally in 2025 [Yahoo! Finance]
Low
Report
Assessing AtriCure's Valuation After a 33.4% Rally in 2025 [Yahoo! Finance]
12/23
03:17 pm
atrc
Analysts See an Over 26% Upside in AtriCure (ATRC) [Yahoo! Finance]
Low
Report
Analysts See an Over 26% Upside in AtriCure (ATRC) [Yahoo! Finance]
12/17
08:00 am
atrc
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
Low
Report
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
12/16
10:45 am
atrc
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Low
Report
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
12/13
02:18 pm
atrc
AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human Success - Has The Bull Case Changed? [Yahoo! Finance]
Medium
Report
AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human Success - Has The Bull Case Changed? [Yahoo! Finance]
12/11
08:00 am
atrc
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
Low
Report
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
11/20
07:04 pm
atrc
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Medium
Report
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
11/20
06:42 am
atrc
AtriCure (ATRC): Exploring Valuation After Recent Share Price Momentum [Yahoo! Finance]
Medium
Report
AtriCure (ATRC): Exploring Valuation After Recent Share Price Momentum [Yahoo! Finance]
11/18
08:00 am
atrc
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/10
04:44 pm
atrc
AtriCure, Inc. (ATRC) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Low
Report
AtriCure, Inc. (ATRC) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/8
12:52 pm
atrc
AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
Low
Report
AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
10/30
08:07 am
atrc
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Medium
Report
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
10/30
06:04 am
atrc
AtriCure (NASDAQ:ATRC) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
AtriCure (NASDAQ:ATRC) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
10/29
04:01 pm
atrc
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
Medium
Report
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
10/28
08:00 am
atrc
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
Low
Report
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
10/27
08:00 am
atrc
AtriCure to Participate in Upcoming Investor Conferences
Low
Report
AtriCure to Participate in Upcoming Investor Conferences
10/24
12:16 pm
atrc
AtriCure (NASDAQ:ATRC) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
AtriCure (NASDAQ:ATRC) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.